Related Experiment Video
Updated: Dec 22, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNA SNHG7 promotes malignant melanoma progression through negative modulation of miR-9
Wendi Wang1, Guangjing Liu1, Man Liu1
1Department of Plastic and Burn Surgery, Tianjin First Center Hospital, Tianjin, China.
Abstract:
Long non-coding small nucleolar RNA host gene 7 (lncRNA SNHG7) was verified to act as an onco-gene in human cancers. Nevertheless, the role of SNHG7 in malignant melanoma remains elusive. The present study showed an increase of SNHG7 expression in malignant melanoma tissues and cell lines. Besides, SNHG7 knockdown inhibited proliferation and migration in malignant melanoma cells. Bioinformatics analysis demonstrated that SNHG7 functions as a molecular sponge for miR-9 in biological behavior of melanoma cells. And miR-9 could inhibit the expression of PI3KR3 by binding with the 3'-UTR. Furthermore, PI3KR3, pAKT, cyclin D1 and Girdin expression was down-regulated after SNHG7 knockdown by siRNA. In addition, SNHG7 knockdown decreased xenograft growth in vivo. Taken together, this research demonstrated that SNHG7 was an oncogene in malignant melanoma, providing a novel insight for the pathogenesis and new potential therapeutic target for malignant melanoma.
Insights
Long non-coding small nucleolar RNA host gene 7 (SNHG7) drives malignant melanoma progression by sponging miR-9, leading to increased cell proliferation and migration. Targeting SNHG7 offers a potential therapeutic strategy for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA SNHG7 is an oncogene in various human cancers.
- The specific role of SNHG7 in malignant melanoma pathogenesis is not well understood.
Purpose of the Study:
- To investigate the expression and function of SNHG7 in malignant melanoma.
- To elucidate the molecular mechanism underlying SNHG7's role in melanoma progression.
Main Methods:
- Analysis of SNHG7 expression in melanoma tissues and cell lines.
- SNHG7 knockdown using siRNA.
- Bioinformatics analysis to identify miRNA interactions.
- Western blotting to assess protein expression levels.
- In vivo xenograft studies.
Main Results:
- SNHG7 expression was significantly upregulated in malignant melanoma.
- SNHG7 knockdown inhibited melanoma cell proliferation and migration.
- SNHG7 acted as a molecular sponge for miR-9.
- miR-9 targeted PI3KR3, and SNHG7 knockdown led to decreased expression of PI3KR3, pAKT, cyclin D1, and Girdin.
- SNHG7 knockdown suppressed tumor growth in vivo.
Conclusions:
- SNHG7 functions as an oncogene in malignant melanoma.
- The SNHG7/miR-9/PI3KR3 axis plays a critical role in melanoma development.
- SNHG7 represents a potential therapeutic target for malignant melanoma.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Experimental RNAi

